Delivery Order SPE2DB24D2101-SPE2DB25FKMVE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,897.50 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count units) under a firm fixed price contract. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Risperdal 0.5 mg tablets (60-count packages) with a contract value of $1,130.40. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Risperdal 2 mg tablets (60-count) with a contract value of $19,929.37. The award is competitively awarded with no set-aside designation and is classified as a firm fixed-price delivery order. This order is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,092.81 firm fixed price delivery order is for the supply of Risperdal 0.5 mg tablets. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 18, 2025, procures 60 tablets of Risperdal 2 mg with a ceiling value of $4,281.44. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency's Medical Supply Chain and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This award was competitively awarded with no set-aside designation and represents a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,062.01 Firm Fixed Price delivery order contract is for the supply of RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025 and was awarded on July 16, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded a $2,120.22 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 Risperdal 2 mg tablets. The delivery order was issued under an existing prime vendor contract vehicle and will be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania. Performance is required between July 11-12, 2023. As the DLA supports military medical readiness through its pharmaceutical contracts, this delivery order for...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,672 to Amerisourcebergen Drug Corporation for the provision of 60 Risperdal 2 mg tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 16, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award...
- This federal contract award, valued at $1,573.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Risperdal 2 mg tablets. It is a Firm Fixed Price, Delivery Order type contract with a completion date of June 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency Troop Support Medical awarded a $153.49 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 60 tablets of 0.5 mg Risperdal. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to the place of performance in Conshohocken, Pennsylvania within the period of performance from August 22 to August 23, 2023. The Defense Logistics Agency supports Department of Defense programs by procuring...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMVEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,373.84 to AmerisourceBergen Drug Corp for Risperdal 0.5 mg tablets (60-count units) with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a critical vendor within the DLA's Medical Supply Chain for delivering essential medications and medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/28/25 |